Biogen
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Biogen
- Company name
- Biogen
- Organisation type
- Industry
- Registered legal name
- BIOGEN INC.
- US industry code (SIC)
- Biological products, (no disgnostic substances)
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0000875045
- Legal Entity Identifier (LEI)
- W8J5WZB5IY3K0NDQT671
Related records
Trials (670)
- 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants
- 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
- 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
- 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
- 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
- 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL
- A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
- A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS
- A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
- A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers
- A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
- A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis
- A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
- A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
- A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
- A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
- A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
- A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen
- A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
- A Human AME Study for Omaveloxolone